Quidelortho Corporation · NASDAQ:QDEL
Quidelortho — Merger or Acquisition (June 2025)
7 slides from Quidelortho's merger presentation, Jun 3, 2025
Slide 1: QuidelOrtho Announces Strategy to Accelerate Growth in Molecular Diagnostics
June 3, 2025 QuidelOrtho Announces Strategy to Accelerate Growth in Molecular Diagnostics Investor Conference Call
Slide 2: Forward-looking Statements
Forward-looking Statements This presentation contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are any statement contained herein that is not strictly historical, including, but not limited to, QuidelOrtho’s intent to a
Slide 3: Overview of Strategy to Accelerate Growth in Molecular Diagnostics
Overview of Strategy to Accelerate Growth in Molecular Diagnostics QuidelOrtho intends to acquire full ownership of LEX Diagnostics for consideration at closing of approximately $100 million, upon U.S. Food and Drug Administration (FDA) clearance, expected late 2025 or early 2026 Intent to Acquire
Slide 4: LEX Diagnostics Technology Overview
LEX Diagnostics Technology Overview Gold Standard PCR at Ultra-Fast Speeds An innovative molecular diagnostics company developing products designed to enhance patient care by delivering clinical insights within minutes and at the time they are most valuable Ultra-fast thermal cycling technology
Slide 5: Innovative Technology and Faster Path to Commercialization
Innovative Technology and Faster Path to Commercialization QuidelOrtho’s strategy for the proposed acquisition of LEX Diagnostics upon FDA clearance: Accelerates Provides Innovative Seamless Fit Provides Near-Term Strengthens Long- Entry into High- Technology with Within Existing Commercial Term Gro
Slide 6: Full-Year 2025 Financial Guidance Reaffirmed
Full-Year 2025 Financial Guidance Reaffirmed Financial Guidance FY 20251 $2.60B–$2.81B2 $575M–$615M 22% $2.07-$2.57 Total Revenues Adjusted EBITDA Adjusted EBITDA Margin Adjusted Diluted EPS (reported) Assumptions: Please see page 6 of the “First Quarter 2025 Financial Results” presentation on the “
Slide 7: quidelortho.com
ae SAMMI quidelortho.co